Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are collecting detailed information about patients with venous thromboembolism VTE to improve understanding of this condition, especially in groups often excluded from clinical trials such as pregnant women, elderly patients, and those with severe health issues. This observational registry aims to provide data that can help reduce death rates, recurrences of blood clots, bleeding problems, and arterial events related to VTE. This study gathers clinical details about each patient, including other health conditions, and tracks the type, dose, duration, and results of antithrombotic treatments over the first three months. The registry is accessible online to assist doctors in managing complex cases by comparing patient profiles and identifying those at higher risk of complications. Participants clinical status and treatment outcomes are recorded, focusing on recurrence of VTE, bleeding events, and mortality over a three-year period. The information supports the creation of predictive scores to help healthcare providers identify patients at higher risk. The study started in 2001 and plans to continue until 2027, with ongoing data collection and follow-up.
Actively Recruiting
Sepsis affects millions worldwide each year and remains a leading cause of death despite medical advances. Early and effective treatment is crucial, especially managing fluids and blood pressure. This trial evaluates whether a personalized treatment strategy guided by non-invasive hemodynamic monitoring using the NICaS device improves survival compared to the standard fluid therapy recommended by international sepsis guidelines. Participants are randomly assigned to either a usual-care group receiving fluid resuscitation and vasopressors based on standard clinical signs or to a group guided by NICaS monitoring. The NICaS device measures heart and circulation parameters non-invasively, helping tailor fluid and vasopressor therapy. Fluid challenges and repeated assessments every three hours during the first 12 hours guide treatment adjustments in the NICaS group, while the usual-care group follows standard protocols. Participants will be monitored closely during their hospital stay and for 30 days after enrollment. Assessments include vital signs, fluid intake and output, blood tests, organ function scores, and clinical status. Researchers will compare survival rates, organ support needs, vasopressor use, kidney function, fluid balance, and predict patient outcomes using hemodynamic data combined with common scoring systems. The study aims to determine if this approach can lead to faster stabilization and better outcomes for septic patients.